Nu-Med Plus (NUMD) EPS (Basic) Growth (3y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.72% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 58.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 5.98% |
| 10 | Nu-Med Plus | - | - | - | -31.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.68% |
| Sep 30, 2025 | 41.84% |
| Jun 30, 2025 | 42.43% |
| Mar 31, 2025 | 31.79% |
| Dec 31, 2024 | 56.46% |
| Sep 30, 2024 | 46.89% |
| Jun 30, 2024 | 59.26% |
| Mar 31, 2024 | 61.28% |
| Dec 31, 2023 | 58.93% |
| Sep 30, 2023 | 72.78% |
| Jun 30, 2023 | 75.37% |
| Mar 31, 2023 | 52.78% |
| Dec 31, 2022 | 28.38% |
| Sep 30, 2022 | 39.67% |
| Jun 30, 2022 | 48.95% |
| Mar 31, 2022 | 57.79% |
| Dec 31, 2021 | 46.50% |
| Sep 30, 2021 | 46.96% |
| Jun 30, 2021 | 11.06% |
| Mar 31, 2021 | -7.11% |
| Dec 31, 2020 | -27.98% |
| Sep 30, 2020 | -41.22% |
| Jun 30, 2020 | -85.93% |
| Mar 31, 2020 | -26.62% |
| Dec 31, 2019 | 22.76% |
| Sep 30, 2019 | 45.06% |
| Jun 30, 2019 | 18.07% |
| Mar 31, 2019 | -26.69% |
| Dec 31, 2018 | 64.84% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 24.24% |
| Mar 31, 2018 | -3.04% |
| Dec 31, 2017 | 93.16% |
| Sep 30, 2017 | 29.19% |
| Jun 30, 2017 | 32.24% |
| Mar 31, 2017 | 196.97% |
| Sep 30, 2016 | -25.99% |
| Jun 30, 2016 | -104.94% |
| Mar 31, 2016 | 371.17% |
| Dec 31, 2015 | -169.36% |
| Mar 31, 2015 | -30.60% |